在第一个情绪抑郁情节期间治疗耐药抑郁症的发生率
Maroua Said1, Rania Hosni2, Hend Jemli2
1Public Mental Health Establishment in Marne (France)..
La Tunisie medicale
|January 24, 2024
概括
治疗耐药性抑郁症 (TRD) 影响了第一个主要抑郁症 (MDD) 发作患者的19.4%. 精神病和慢性呼吸道问题的家族病史与TRD有关,这表明需要考虑遗传和并发症来制定更好的治疗策略.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐治疗抑郁症 (TRD) 尽管存在现有疗法,但仍面临重大挑战.
- 需要不断完善TRD的治疗策略.
研究的目的:
- 为了确定 TRD 在经历第一次重大抑郁发作 (MDD) 的人群中的发生率.
- 为了确定与MDD患者治疗耐药性相关的因素.
主要方法:
- 进行了一项前性纵向研究,涉及第一个MDD的门诊患者.
- 患者接受了选择性血清素再吸收抑制剂 (SSRI),并对治疗反应或TRD标准进行监测.
- 排除标准包括曾经患有门以下低迷症.
主要成果:
- 这项研究在82名成年参与者中观察到TRD的发病率为19.4% (CI95%=[5.5-33.3]).
- 精神病 (p=0.038) 和慢性呼吸道并发症 (p=0.016) 的家族病史与TRD有显著的关联.
- 限制包括小样本规模和仅使用两个SSRI.
结论:
- 在这项研究中,TRD的发病率处于报告率的下端.
- 临床因素表明,基因型分析对于识别TRD风险患者的潜在实用性.
- 伴随性疾病对于优化护理至关重要,为了概括性,建议进行更大的多中心研究.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
234
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
234
Mania and Antimanic Drugs: Overview
181
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
181
Depressive Disorders: MDD and Dysthymia
136
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
136
Bipolar Disorder
67
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
67
Electroconvulsive Therapy
41
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
41
Depressive Disorders: Etiology
102
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
102


